Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

According to Kiran Jones, a clinical pharmacist at Oxford Online Pharmacy, some of the most concerning side effects of GLP-1 ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

A doctor is breaking down the biggest myths about popular weight loss trends, revealing whether or not these fads actually ...

Drugs like Ozempic and Mounjaro are GLP-1-based medications, meaning they mimic gut hormones that help regulate appetite and ...